Nifty Pharma holds flat as Sensex recovers 484 points from intraday low. Jatin Gedia flags rupee tailwind and technical support for defensive bid. Metal, realty, auto lead losses.
The BSE Sensex and Nifty 50 recovered roughly half their early-session losses by Monday afternoon, though both remained in negative territory. The Sensex traded 440 points lower at 73,803.13 after hitting an intraday low of 73,318.94. The Nifty 50 declined 145 points to 23,221.45, recovering from a 296-point drop from the previous close. The intraday bounce from a 924-point Sensex plunge was not enough to flip the tape positive. Sectoral dispersion told the real story: metal, realty, and auto indices fell over 1%, while the Nifty Pharma index held flat, extending its relative outperformance from the past month.
The session's action fits a pattern that has repeated through the first half of calendar 2026: broad-based selling pressure that spares the defensive clusters. Jatin Gedia, Vice President – Technical Research at Teji Mandi, noted that the pharma index has delivered nearly 1% returns over the past month even as most sectoral indices remained under pressure. On a year-to-date basis, the pharma index has gained around 7%, making it the second-best performing sector during a volatile first half.
The mechanism behind the pharma bid is not simply a rotation into safety. Three specific drivers are operating in parallel, and each has a different durability profile.
When the Nifty 50 falls more than 0.5% and market breadth shows 2,187 decliners against 967 advancers, institutional flow typically rotates toward sectors with inelastic demand. Pharma and FMCG fit that description. Gedia described them as traditional defensive bets during periods of heightened market volatility. The data supports the label: the pharma index has held its uptrend while the broader market has given back gains.
A second mechanism is specific to pharma's revenue structure. A weaker rupee inflates the rupee-denominated value of export revenue, which for many Indian pharma companies represents 40-60% of total sales. Gedia explicitly cited the depreciation in the rupee as a factor supporting earnings sentiment. This is not a valuation story. It is a translation effect on the P&L. If the rupee stabilises or reverses, that tailwind fades.
Gedia noted that most pharma stocks remain in an uptrend, with buying interest emerging on declines toward key support levels. This creates a self-reinforcing dynamic: traders who missed the first leg buy the dip, which validates the support, which attracts more dip buyers. The risk is that a break below those levels would trigger the opposite cascade.
Practical rule: A sector that holds support while the index breaks it is either a genuine safe haven or a crowded trade that will liquidate violently when the rotation ends. The difference is in the catalyst. If the rupee strengthens or a risk-on rotation resumes, pharma's relative bid disappears.
Metal, realty, and auto indices declined over 1% each. These are the sectors most exposed to domestic demand expectations and global commodity pricing. When the tape turns negative, these are the first to be cut because their earnings sensitivity to economic growth is high and their valuation multiples are often extended.
IT stocks also remained under pressure but were off the day's low. The IT sector faces a different headwind: US demand uncertainty and a strong dollar that, while beneficial for rupee revenue translation, also signals weaker global growth. The sector's intraday recovery from lows suggests some dip-buying, the trend remains cautious.
Healthcare, pharma, FMCG, and media indices traded largely flat. Within this group, pharma has the strongest relative momentum. Gedia's preferred picks in the pharma space include Laurus Labs, Zydus Life, Glenmark Pharma, and Gland Pharma. These names represent a mix of API manufacturers and branded formulations players, each with different exposure to the rupee tailwind and USFDA approval cycles.
Broader markets remained under pressure. Small-cap indices continued to trade nearly 1% lower. Mid-cap indices staged a mild recovery from intraday lows but did not turn positive. The divergence between mid-caps and small-caps is consistent with a market that is willing to buy quality mid-cap names on dips but is not yet ready to reach for the higher-beta small-cap space.
In the mid-cap segment, Fortis Healthcare, Alkem Laboratories, Oil India, LG Electronics, and Voltas gained 2-4%. On the losing side, GE Vernova T&D, Hitachi Energy, SAIL, Aditya Birla Capital, and Kalyan Jewellers fell 3-4%. The winners were concentrated in healthcare and select industrials. The losers were in metals and capital goods.
Among small-cap stocks, Netweb Technologies, IFCI, FSL, and Urban Company declined 4-7%. On the other hand, Meesho, Syngene, Aster DM Healthcare, PWL, and Karur Vysya Bank gained 3-4%. The small-cap list reinforces the same theme: healthcare names are finding bids, while cyclicals and financials are under pressure.
Of the 3,256 stocks traded on the NSE at around 12:35 pm, 967 advanced, 2,187 declined, and 102 remained unchanged. That is a 2.3-to-1 decliner-to-advancer ratio. A ratio above 2-to-1 is consistent with a distribution day, where institutional selling is broad rather than concentrated in a single sector.
Nearly 72 stocks touched their 52-week highs, while 63 hit fresh 52-week lows. The near-parity between highs and lows is unusual for a session where the index is down 0.6%. It suggests that the selling is not indiscriminate. Stocks that have strong fundamentals or sector tailwinds are still finding buyers at new highs, while weak names are being abandoned.
75 stocks were locked in the upper circuit, while 95 hit the lower circuit limit. The lower circuit count exceeding the upper circuit count is consistent with a bearish session. The absolute numbers are not extreme. A panic session would show 200+ stocks in lower circuit.
Max Healthcare, Power Grid, Apollo Hospitals, and Tech Mahindra emerged as the top gainers among Nifty 50 constituents. Three of the four are healthcare or healthcare-adjacent. Power Grid is a utility with regulated returns, which also qualifies as a defensive holding during risk-off sessions.
Wipro, IndiGo, Shriram Finance, Hindalco, and Eternal declined between 2% and 7%. The losers span IT, aviation, financials, metals, and consumer goods. The breadth of the losing list confirms that the selling is sector-agnostic for names that have weak relative momentum or specific company-level headwinds.
Adani Energy hit a 52-week high during the session, while other Adani group stocks traded flat amid weak market sentiment. A single stock hitting a new high while the broader group is flat is a stock-specific story, not a group-wide re-rating. It suggests that the market is differentiating between Adani entities based on business model and cash flow visibility rather than trading them as a bloc.
The session's intraday recovery from the lows is the most actionable data point for the near term. The Sensex bounced from 73,318.94 to 73,803.13, a recovery of roughly 484 points from the low. The Nifty 50 recovered from its intraday low by about 150 points. If the indices hold above those intraday lows on any further selling in the next two sessions, the bounce has technical credibility. If the indices break below those lows, the recovery was a dead-cat bounce and the next leg lower is in play.
For sector-specific positioning, the pharma bid is the cleanest relative-value trade in the current tape. It is a trade, not a long-term allocation. The catalyst that breaks it is a shift in the macro narrative, not a change in pharma fundamentals. Traders holding pharma longs should have a defined exit level tied to the Nifty Pharma index support, not to the stock price of any single holding.
HTHIY (Hitachi Ltd) carries an Alpha Score of 65/100 with a Moderate label in the Industrials sector. The stock page is available at HTHIY stock page. For traders tracking the industrial and capital goods space, Hitachi Energy's 3-4% decline in the mid-cap segment is a reminder that even high-quality industrials are not immune to the current risk-off rotation.
The session's message is straightforward: the market is not in panic mode, it is in selective mode. Defensives hold. Cyclicals bleed. The trader's job is to stay on the right side of that divide until the macro catalyst shifts.
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.